
10mg each
$89.95
$67.46
This synergistic combination blend contains 10mg of CJC-1295 (Modified GRF 1-29) and 10mg of Ipamorelin in a single 2ml vial, designed for comprehensive growth hormone secretion research. CJC-1295 is a modified growth hormone-releasing hormone (GHRH) analog with an extended half-life, while Ipamorelin is a selective growth hormone secretagogue peptide (GHRP) that stimulates GH release without affecting cortisol or prolactin levels. Together, these peptides provide researchers with a powerful tool for studying pulsatile growth hormone release, IGF-1 pathway activation, and metabolic regulation. This blend is ideal for advanced research protocols investigating combined GHRH and GHRP effects on growth hormone dynamics, body composition changes, and anabolic signaling pathways.
Store lyophilized powder at -20°C in original sealed vial in a dry environment protected from light. After reconstitution with bacteriostatic water or sterile saline, store at 2-8°C and use within 14 days. For extended storage of reconstituted peptide, aliquot and store at -20°C. Avoid repeated freeze-thaw cycles which may reduce peptide stability. Reconstitute under aseptic conditions in a laminar flow hood. Allow vial to reach room temperature before opening to prevent condensation.
This product is intended for laboratory research use only. It is not intended for human consumption, medical, veterinary, or household use. This material should only be handled by qualified professionals in appropriate laboratory settings following proper safety protocols.
By purchasing this product, you acknowledge that you are a qualified researcher and will use this material solely for legitimate research purposes in compliance with all applicable laws and regulations.